New Publication Shows Cleviprex™ Provides More Precise Blood Pressure Control In Cardiac Surgery Patients

October 7th, 2008 by admin

The Medicines Company (NASDAQ: MDCO) declared that ECLIPSE, the maximal country information to fellow scrutiny intravenous medication therapies, has been publicised in the Oct supply of Anesthesia and Analgesia. Results exhibit Cleviprex™ (clevidipine butyrate) injectable coat is innocuous and trenchant for managing murder push in patients undergoing cardiac surgery and provides more fine murder push curb than threesome commonly utilised IV antihypertensives.

Tags: ,

Posted in Cardiology |

Related posts

Comments are closed.